D. E. Shaw & Co »

Alnylam Pharmaceuticals shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2013-03-31 $7.1M 293k 24.37
2012-12-31 $2.1M 113k 18.25
2012-06-30 $1.8M 157k 11.67
2012-03-31 $1.4M 126k 11.06

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A Put Option (META)
Amazon (AMZN)
Tesla Motors Put Option (TSLA)
Netflix Put Option (NFLX)
Booking Holdings Call Option (BKNG)
Advanced Micro Devices Put Option (AMD)
Broadcom Put Option (AVGO)
Eli Lilly & Co. Call Option (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Bank of America Corporation (BAC)
Palantir Technologies Cl A (PLTR)
Citigroup Com New Put Option (C)

View all positions for D. E. Shaw & Co

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
FMR
Vanguard Group
BlackRock
Capital Research Global Investors
Wellington Management Company
Baillie Gifford & Co
Capital Research and Management Company - Division 3
Dodge & Cox
State Street Corporation
T. Rowe Price Associates
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
American Century Companies

View all funds holding Alnylam Pharmaceuticals